💉 Awiqli® Once-Weekly Insulin Launches in India: A Major Breakthrough in Diabetes Care
India has welcomed Awiqli® (insulin icodec), the world's first once-weekly basal insulin from Novo Nordisk for adults living with Type 1 and Type 2 diabetes.
Instead of daily basal insulin injections, eligible patients may now require just one injection per week, making long-term diabetes management more convenient and potentially improving treatment adherence.
Key Highlights
✔ World's first once-weekly basal insulin ✔ Designed for adults with Type 1 & Type 2 diabetes ✔ Launched by Novo Nordisk in India ✔ A significant advancement in diabetes care and healthcare innovation
🔗 Read the full article:
Follow UnboxDailyHQ for the latest updates on technology, healthcare, pharmaceuticals, AI, automobiles, government initiatives, and innovation.












